| Stage | BAH | % of rev | ELAN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.8B | 100.00% | $1.4B | 100.00% | BAH ×2.03 |
| Gross profit | $1.4B | 52.02% | $798M | 58.33% | ELAN +6.3pp |
| Operating income | $245M | 8.82% | $115M | 8.41% | BAH +0.4pp |
| Pre-tax income | $199M | 7.16% | $56M | 4.09% | BAH +3.1pp |
| Net income | $181M | 6.52% | $54M | 3.95% | BAH +2.6pp |
| Stage | BAH | ELAN | Gap · A − B |
|---|---|---|---|
| Revenue | $2.8B100.00% | $1.4B100.00% | BAH ×2.03 |
| Gross profit | 52.02%$1.4B | 58.33%$798M | ELAN +6.3pp |
| Operating income | 8.82%$245M | 8.41%$115M | BAH +0.4pp |
| Pre-tax income | 7.16%$199M | 4.09%$56M | BAH +3.1pp |
| Net income |
| 6.52%$181M |
| 3.95%$54M |
| BAH +2.6pp |
No shared counterparties.